Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics.

Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Clin Infect Dis. 2011 Aug 1;53(3):234-44. doi: 10.1093/cid/cir321.

2.

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Pai M, Zwerling A, Menzies D.

Ann Intern Med. 2008 Aug 5;149(3):177-84. Epub 2008 Jun 30. Review.

3.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25.

4.

Discordance among commercially available diagnostics for latent tuberculosis infection.

Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Am J Respir Crit Care Med. 2012 Feb 15;185(4):427-34. doi: 10.1164/rccm.201107-1244OC. Epub 2011 Dec 8.

5.

Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review.

Moon HW, Hur M.

Ann Clin Lab Sci. 2013 Spring;43(2):221-9. Review.

PMID:
23694799
6.
7.

Interferon gamma release assays: principles and practice.

Lalvani A, Pareek M.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Review.

PMID:
19783328
8.

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.

Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL; Tuberculosis Epidemiologic Studies Consortium.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):77-87. doi: 10.1164/rccm.201302-0365OC.

PMID:
24299555
9.

Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.

Bergamini BM, Losi M, Vaienti F, D'Amico R, Meccugni B, Meacci M, De Giovanni D, Rumpianesi F, Fabbri LM, Balli F, Richeldi L.

Pediatrics. 2009 Mar;123(3):e419-24. doi: 10.1542/peds.2008-1722.

PMID:
19254978
10.

Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.

Hadaya K, Bridevaux PO, Roux-Lombard P, Delort A, Saudan P, Martin PY, Janssens JP.

Transplantation. 2013 Jun 27;95(12):1485-90. doi: 10.1097/TP.0b013e3182907073.

PMID:
23694948
11.

Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.

Simsek H, Alpar S, Ucar N, Aksu F, Ceyhan I, Gözalan A, Cesur S, Ertek M.

Jpn J Infect Dis. 2010 Mar;63(2):99-102.

12.

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.

Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M.

BMC Infect Dis. 2011 Nov 15;11:319. doi: 10.1186/1471-2334-11-319.

13.

Tests for latent tuberculosis in people with ESRD: a systematic review.

Rogerson TE, Chen S, Kok J, Hayen A, Craig JC, Sud K, Kable K, Webster AC.

Am J Kidney Dis. 2013 Jan;61(1):33-43. doi: 10.1053/j.ajkd.2012.07.019. Epub 2012 Oct 13. Review.

PMID:
23068425
14.

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children.

Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC.

PLoS One. 2008 Jul 9;3(7):e2624. doi: 10.1371/journal.pone.0002624.

15.

The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H.

Pediatr Infect Dis J. 2011 Aug;30(8):694-700. doi: 10.1097/INF.0b013e318214b915.

PMID:
21427627
16.

Comparison of the 2-step tuberculin skin test and the quantiFERON-TB Gold In-Tube Test for the screening of tuberculosis infection before liver transplantation.

Casas S, Muñoz L, Moure R, Castellote J, Guerra MR, Gonzalez L, Andreu A, Rafecas AG, Alcaide F, Santin M.

Liver Transpl. 2011 Oct;17(10):1205-11.

PMID:
22279622
17.

Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell PC, Pai M.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8. doi: 10.1097/QAI.0b013e31820b07ab. Review.

18.

Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.

Goletti D, Carrara S, Butera O, Amicosante M, Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, Drenska R, Dominguez J, Latorre I, Angeletti C, Navarra A, Petrosillo N, Lauria FN, Ippolito G, Migliori GB, Lange C, Girardi E.

PLoS One. 2008;3(10):e3417. doi: 10.1371/journal.pone.0003417. Epub 2008 Oct 15. Erratum in: PLoS One. 2009;4(6). doi: 10.1371/annotation/9c073390-ed15-44c9-bb85-b64e094e351a. Stefania, Carrara [corrected to Carrara, Stefania].

19.

Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.

Orlando G, Merli S, Cordier L, Mazza F, Casazza G, Villa AM, Codecasa L, Negri E, Cargnel A, Ferrarese M, Rizzardini G.

Infection. 2010 Jun;38(3):195-204. doi: 10.1007/s15010-010-0015-2. Epub 2010 Apr 22.

PMID:
20411295
20.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.

BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.

Supplemental Content

Support Center